SSZ
Product Specifications
UNSPSC Description
SSZ is a multi-target inhibitor, which targets multiple pathological mechanisms of Alzheimer's disease (AD). SSZ targets acetylcholinesterase, butyrylcholinesterase, β-site amyloid precursor protein cleavage enzyme 1 (BACE1), and γ-secretase. SSZ ameliorates Alzheimer’s diseases and exhibits neuroprotective effect in mice[1].
Target Antigen
Beta-secretase; Cholinesterase (ChE); γ-secretase
Type
Reference compound
Related Pathways
Neuronal Signaling;Stem Cell/Wnt
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ssz.html
Smiles
ClC1=CC(C2=CNC3=C2C=CC=N3)=CC(NC4CCCCC4)=N1
Molecular Weight
326.82
References & Citations
[1]Khan MS, et al., Synthesis and Neurobehavioral Evaluation of a Potent Multitargeted Inhibitor for the Treatment of Alzheimer's Disease. Mol Neurobiol. 2024 Jul 15.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-163885/SSZ-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-163885/
Clinical Information
Phase 4
CAS Number
1262287-23-9
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items